The levels of serum autoantibody against SPP1 were significantly higher in patients with ESCC compared to NC in both discovery (62 ESCC VS 62 NC) and validation groups (100 ESCC VS 100 NC). The gene discussed is SPP1; the disease is esophageal squamous cell carcinoma.